Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

CNY 22.31

(5.19%)

Market Cap (In CNY)

12.4 Billion

Revenue (In CNY)

3.31 Billion

Net Income (In CNY)

568.1 Million

Avg. Volume

8.89 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
16.07-27.26
PE
-
EPS
-
Beta Value
0.339
ISIN
CNE000001501
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Wei Xiong
Employee Count
-
Website
https://www.lingrui.com
Ipo Date
2000-10-18
Details
Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.